PATENT CLAIM ANALYSIS

Application Number: 15942840
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["424", "452000"]

Abstract:
The present invention relates to oral liquid compositions of guanfacine. The liquid compositions can be immediate release or extended release compositions. The compositions comprise guanfacine in a concentration from about 0.1 mg/mL to about 12.0 mg/mL of the composition. The liquid compositions can be in the form of ready-to use liquid compositions or reconstituted liquid compositions. It further relates to processes for the preparation of said oral liquid compositions.

Claim (Index 34):
The stable extended release oral liquid composition of  claim 33 , wherein the composition comprises less than about 0.7% w/w of 2, 6-dichlorophenyl acetic acid when stored at 40\u00b0 C. and 75% RH for at least 3 months.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 91.0
- Lexical Diversity: 1.94737
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15144026', '15148131', '15148069', '15607125', '15853219']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6961570313185528
- 35 USC 102 Novelty (BERT): 0.5298905159378544
- Combined Prediction Score: 0.6795303797804829
- Mean Citation Score: 249.933054
- Max Citation Score: 337.39386
- Similarity Product: 291.94753037894725

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test